Benchmark 2026-B44 Mortgage Trust has announced a significant public offering of $701.604 million in commercial mortgage-backed securities (CMBS). This offering is noteworthy as it reflects the ongoing demand for asset-backed securities in the current market. The move is expected to attract attention from investors looking for opportunities in this sector.
Benchmark 2026-B44 Mortgage Trust is classified under the SIC code 6189, which pertains to Asset-Backed Securities. The company is incorporated in Delaware and operates from its headquarters at 200 West Street, New York, NY. Its recent filings include various forms, with the latest being a Free Writing Prospectus filed on November 4, 2026, under accession number 0001539497-26-002849.
The filing outlines that the public offering will be managed by several leading financial institutions, including Goldman Sachs & Co. LLC, Deutsche Bank Securities, BMO Capital Markets, Barclays, J.P. Morgan, UBS Securities LLC, and Citigroup. Co-managers for the offering include Academy Securities and Drexel Hamilton, LLC. This diverse group of underwriters indicates a strong backing for the offering.
The anticipated pricing for the offering is set for the week of November 2, 2026, with a settlement date scheduled for November 20, 2026. The offering includes various classes of certificates, each with expected ratings from agencies such as S&P, Fitch, and KBRA. For instance, Class A-1 is expected to receive ratings of AAA(sf)/AAAsf/AAA(sf) and has a size of approximately $8.810 million.
This offering may impact a range of stakeholders, including investors seeking stable returns from asset-backed securities. The involvement of major financial institutions as underwriters may also enhance confidence in the offering, potentially leading to increased participation from institutional investors.
Details were not available in the SEC filing regarding future steps beyond the anticipated pricing and settlement dates. Investors are encouraged to review the prospectus and other related documents for comprehensive information about the offering.
Read Next
Stryker Corp files registration statement for new securities
Citigroup files preliminary pricing supplement for notes
Pitofsky files to sell 180 shares of Regeneron Pharmaceuticals
Guild Capital - Project C SPV LLC raises $12.5 million in offering
Co-Diagnostics registers 39.6 million shares for sale
Fraga Francisco Files to Sell 600 Shares of McKesson Corp










